DJIA51538.47 188.49
S&P 5007725.61 21.48
NASDAQ27014.77 75.39
Russell 20002836.07 0.49
German DAX25396.22 129.69
FTSE 10010696.17 16.18
CAC 408077.80 -3.63
EuroStoxx 506297.20 24.25
Nikkei 22566364.20 850.21
Hang Seng24510.09 -251.04
Shanghai Comp3888.37 -48.15
KOSPI7080.92 63.01
Bloomberg Comm IDX144.57 -1.37
WTI Crude-fut98.88 -1.08
Brent Crude-fut91.63 -2.66
Natural Gas3.21 -0.07
Gasoline-fut3.23 -0.09
Gold-fut4316.30 8.10
Silver-fut64.49 0.29
Platinum-fut1782.20 14.00
Palladium-fut1265.00 -10.00
Copper-fut6.77 0.00
Aluminum-spot3195.00 0.00
Coffee-fut279.70 3.10
Soybeans-fut1315.25 -1.25
Wheat-fut698.25 -7.50
Bitcoin83907.07 -280.34
Ethereum USD2694.28 11.46
Litecoin69.78 -1.31
Dogecoin0.10 0.00
EUR/USD1.1378 -0.0009
USD/JPY158.89 0.60
GBP/USD1.3219 -0.0022
USD/CHF0.8288 0.0038
USD IDX100.94 -0.32
US 10-Yr TR5.187 0.025
GER 10-Yr TR3.5919 -0.0313
UK 10-Yr TR5.3587 -0.007
JAP 10-Yr TR3.08 -0.002
Fed Funds4 0
SOFR3.88 0.01
High-rise commercial buildings

Sub Markets

Topics

Direct Investment  + M&As  | 
Thoma Bravo, MDP Complete $1.4B Sale of Syntellis to Roper Technologies

Thoma Bravo, MDP Complete $1.4B Sale of Syntellis to Roper Technologies

Private equity firms Madison Dearborn Partners and Thoma Bravo have completed the sale of Syntellis Performance Solutions to Roper Technologies, Inc. in an all-cash transaction valued at $1.4 billion, including a $135 million tax benefit resulting from the transaction.

Syntellis is a provider of cloud-based performance management and data services for healthcare, financial institutions, and higher education. The company will be combined with Roper’s Strata Decision Technology business, which offers healthcare financial planning, decision support and performance management services.

The combined entity will operate under the Strata brand and led by Strata CEO John Martino.

Syntellis became an independent company with the investment support of Thoma Bravo and MDP when it was separated from Kaufman Hall in August 2020. Since then, the company has made product and platform investments, including to its Axiom365 SaaS offering, and enhanced its planning and performance product offering by acquiring Stratasan, a specialist in healthcare market intelligence and data analytics.

With planned cost efficiencies, Syntellis is anticipated to generate $185 million in sales and $85 million in EBITDA in 2024.

Roper used its cash on hand and revolving credit facility to finance the acquisition, which closed earlier this week.

Connect

Inside The Story

Syntellis Performance SolutionsMadison Dearborn PartnersThoma Bravo

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.